Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Cross

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Pathogens (Basel, Switzerland)|December 22, 2023
The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated MechanismsRobert W Cross, Christopher M Wiethoff, Patricia Brown-Augsburger, et al.
Cell|March 18, 2022
Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolavirusesJacob C Milligan, Carl W Davis, Xiaoying Yu, et al.
Cell|June 2, 2021
Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic feverJ Maximilian Fels, Daniel P Maurer, Andrew S Herbert, et al.
Immunity|February 6, 2020
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus NeutralizationPavlo Gilchuk, Charles D Murin, Jacob C Milligan, et al.
The Journal of Infectious Diseases|August 14, 2016
Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus InfectionMatthew L Boisen, Robert W Cross, Jessica N Hartnett, et al.
Cell Host & Microbe|January 11, 2019
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman PrimatesZachary A Bornholdt, Andrew S Herbert, Chad E Mire, et al.
Viral Immunology|December 23, 2014
Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreakMatthew L Boisen, John S Schieffelin, Augustine Goba, et al.
The Journal of Infectious Diseases|August 2, 2015
Development of Prototype Filovirus Recombinant Antigen ImmunoassaysMatt L Boisen, Darin Oottamasathien, Abigail B Jones, et al.
The Journal of Infectious Diseases|September 3, 2016
Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus InfectionRobert W Cross, Matthew L Boisen, Molly M Millett, et al.
Ebiomedicine|March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Pathogens (Basel, Switzerland)|December 22, 2023
The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated MechanismsRobert W Cross, Christopher M Wiethoff, Patricia Brown-Augsburger, et al.
Cell|March 18, 2022
Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolavirusesJacob C Milligan, Carl W Davis, Xiaoying Yu, et al.
Cell|June 2, 2021
Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic feverJ Maximilian Fels, Daniel P Maurer, Andrew S Herbert, et al.
Immunity|February 6, 2020
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus NeutralizationPavlo Gilchuk, Charles D Murin, Jacob C Milligan, et al.
The Journal of Infectious Diseases|August 14, 2016
Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus InfectionMatthew L Boisen, Robert W Cross, Jessica N Hartnett, et al.
Cell Host & Microbe|January 11, 2019
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman PrimatesZachary A Bornholdt, Andrew S Herbert, Chad E Mire, et al.
Viral Immunology|December 23, 2014
Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreakMatthew L Boisen, John S Schieffelin, Augustine Goba, et al.
The Journal of Infectious Diseases|August 2, 2015
Development of Prototype Filovirus Recombinant Antigen ImmunoassaysMatt L Boisen, Darin Oottamasathien, Abigail B Jones, et al.
The Journal of Infectious Diseases|September 3, 2016
Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus InfectionRobert W Cross, Matthew L Boisen, Molly M Millett, et al.
Ebiomedicine|March 29, 2025
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Pageof 13